Purpose: To identify and synthesize the research evidence concerning (1) the relationship between physical activity and cognitive performance in persons with multiple sclerosis (MS) and (2) to review the reported effects of physical activity interventions on neurocognitive performance conducted in this population.

The U.S. Food and Drug Administration today allowed marketing of the inFlow Intraurethral Valve-Pump, a replaceable urinary prosthesis for use in female adults who cannot contract the muscles necessary to push urine out of the bladder (impaired detrusor contractility or IDC).

In September, the Centers for Disease Control and Prevention (CDC) issued a Health Advisory to healthcare professionals nationwide to be vigilant for and report cases of neurologic illnesses associated with limb weakness that meet the criteria of its case definition.

On February 4, 2014, Genzyme, a Sanofi company, announced that Mexico’s
national regulatory authority, COFEPRIS, has approved Lemtrada
(alemtuzumab) for the treatment of patients with relapsing remitting
forms of multiple sclerosis (MS) to slow or reverse the accumulation of
physical disability and reduce the frequency of clinical exacerbations.

On January 28, 2014, Teva Pharmaceutical Industries Ltd. announced that the new, three-times-per-week dosing of Copaxone® (glatiramer acetate), at the more concentrated dose of 40 mg, has been approved by the FDA.

In addition, on April 20, 2012, the European Medicines Agency (EMA) issued a press release outlining changes to the recommended use of Gilenya in the European Union (Summary of Product Characteristics). These recommendations do not apply to the U.S.

This intensive, two-day course on contemporary topics in MS is led by faculty who are thought leaders in MS nursing. The program will be held Monday through Wednesday, May 28-30, 2012 at the Hilton San Diego Bayfront, immediately preceding the CMSC Annual Meeting in San Diego, California.

To apply for the program you must be a nurse with an interest in MS who is based in the United States or Canada. Please complete the application to apply for the program.

Space is limited to 40 nurses, apply by March 9, 2012! Please contact Katie at 877-444-8435 ext. 159 or
if you have any questions.